Screening an In-House Isoquinoline Alkaloids Library for New Blockers of Voltage-Gated Na+ Channels Using Voltage Sensor Fluorescent Probes: Hits and Biases
Abstract
Voltage-gated Na+ (Na-V) channels are significant therapeutic targets for the treatment of cardiac and neurological disorders, thus promoting the search for novel Na-V channel ligands. With the objective of discovering new blockers of Na-V channel ligands, we screened an In-House vegetal alkaloid library using fluorescence cell-based assays.
We screened 62 isoquinoline alkaloids (IA) for their ability to decrease the FRET signal of voltage sensor probes (VSP), which were induced by the activation of Na-V channels with batrachotoxin (BTX) in GH3b6 cells. This led to the selection of five IA: liriodenine, oxostephanine, thalmiculine, protopine, and bebeerine, inhibiting the BTX-induced VSP signal with micromolar IC50.
These five alkaloids were then assayed using the Na+ fluorescent probe ANG-2 and the patch-clamp technique. Only oxostephanine and liriodenine were able to inhibit the BTX-induced ANG-2 signal in HEK293-hNa(V)1.3 cells.
Indeed, liriodenine and oxostephanine decreased the effects of BTX on Na+ currents elicited by the hNa(V)1.3 channel, suggesting that conformation change induced by BTX binding could induce a bias in fluorescent assays. However, among the five IA selected in the VSP assay, only bebeerine exhibited strong inhibitory effects against Na+ currents elicited by the hNav1.2 and hNav1.6 channels, with IC50 values below 10 mu M.
So far, bebeerine is the first BBIQ to have been reported to block Na-V channels, with promising therapeutical applications.